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We assessed the role of PGC-1α (PPARγ coactivator-1 alpha) in glucose-induced proliferation, migration, and inﬂammatory
gene expression of vascular smooth muscle cells (VSMCs). We carried out phagocytosis studies to assess the role of PGC-1α in
transdiﬀerentiation of VSMCs by ﬂow cytometry. We found that high glucose stimulated proliferation, migration and inﬂamma-
tory gene expression of VSMCs, but overexpression of PGC-1α attenuated the eﬀects of glucose. In addition, overexpression of
PGC-1α decreased mRNA and protein level of VSMCs-related genes, and induced macrophage-related gene expression, as well as
phagocytosisofVSMCs.Therefore,PGC-1αinhibitedglucose-inducedproliferation,migrationandinﬂammatorygeneexpression
of VSMCs, which are key features in the pathology of atherosclerosis. More importantly, PGC-1α transdiﬀerentiated VSMCs to
a macrophage-like state. Such transdiﬀerentiation possibly increased the portion of VSMCs-derived foam cells in the plaque and
favored plaque stability.
1.Introduction
Activation of vascular smooth muscle cells (VSMCs) in-
cluding proliferation, migration, and inﬂammatory gene
expression plays an important role in the development of
atherosclerosis. In early atherosclerosis, VSMCs may con-
tribute to the development of the atheroma through the
production of preinﬂammatory mediators such as monocyte
chemoattractant protein-1 (MCP-1) [1]. VSMC-derived
foam cells have been demonstrated in vitro [2]a n din
vivo atherosclerotic plaques [3]. These foam cells assume a
macrophage-like state [4].
Hyperglycemia has been implicated as a major con-
tributor to several diabetes complications by inducing key
factors including oxidant stress and inﬂammatory gene
expression [5]. Furthermore, these factors may also lead to
abnormal proliferation, migration and inﬂammatory gene
expressionofVSMCs,whicharekeyfeaturesinthepathology
of atherosclerosis. Recent studies have demonstrated that
treatment of cultured VSMCs in vitro with diabetogenic
agents such as high glucose can increase the production of
various proinﬂammatory cytokines and chemokines, which
are all associated with vascular inﬂammation [6].
PPARγ coactivator-1 alpha (PGC-1α) is originally iden-
tiﬁed as a transcriptional coactivator of PPARγ [7]. PGC-
1α can coactivate many nuclear receptors such as liver X
receptor [8], and nonnuclear receptors such as Sry-related
HMG box-9 [9]. As a metabolic regulator, PGC-1α functions
in adaptive thermogenesis in brown fat [7], gluconeogenesis
in liver [10], and insulin secretion in islets [11]. Our group
has demonstrated that PGC-1α is an important negative
regulator for VSMC proliferation and migration under
pathophysiological conditions, such as oleic acid stimulation
[12]. Additionally, PGC-1α participates in the diﬀerentiation
procedure including adipocyte diﬀerentiation [7]a n dc h o n -
drogenesis [9].
In the present study, we assessed the role of PGC-1α in
glucose-induced proliferation, migration, and inﬂammatory
gene expression of VSMCs. We also carried out phagocytosis
studies to assess the role of PGC-1α in transdiﬀerentiation of2 Journal of Biomedicine and Biotechnology
Table 1: Primer sequences for qRT-PCR, all sequences are from 5  to 3 .
Genes Forward primer Reverse primer
β-actin AGGGAAATCGTGCGTGAC CGCTCATTGCCGATAGTG
Myosin heavy chain TCCGTGGGTGCAAATAAGG CCGCTCCCAACCATCAACT
SM22α GAGGACTGTAATGGCTTTGG GCCTTCCCTTTCTAACTGATG
Calponin H1 GCACCAATAAGTTTGCCAGTC GAGCGTGTCACAGTGTTCCAT
α-actin TCCTGACCCTGAAGTATCCG ATCTCCAGAGTCCAGCACAA
CD68 CTGACCTTGCTGGTACTGCT GGTCGTAGGGCTTGCTGT
Mac-2 CCTACGATATGCCCTTGCC CCCAGTTATTGTCCTGCTTC
ABCA-1 CCTGCTGAAATACCGACAA TGAGGGACGATTCCACAT
MCP-1 GCCTG TTGTTCACAGTTGC TTCTGGACCCATTCCTTATT
IL-6 GAGTTCCGTTTCTACCTG CTTAGCCACTCCTTCTGT
VSMCs. We found that PGC-1α inhibited glucose-induced
VSMCs proliferation, migration, and inﬂammatory gene
expression and furthermore resulted in phenotypic changes
of VSMCs to a macrophage-like state.
2.MaterialsandMethods
2.1. Materials. Carboxylate-modiﬁed microspheres (F8821)
with red ﬂuorescent were purchased from Molecular Probes
(Eugene, OR). RNeasy kit (cat. no.74104) and RNase-free
DNase I (cat. no. 79254) were from QIAGEN. SYBR green
PCR master mix (Part no.: 4309155) was from Applied
Biosystems.
2.2. Cell Culture. Rat aortic VSMCs were isolated from
the thoracic aortas of 3- to 4-week-old male Sprague-
Dawley rats as described previously [13]. Isolated VSMCs
were cultured in DMEM with 25mmol/L or 5.5mmol/L D-
glucose (Gibco-Invitrogen, Carlsbad, USA), supplemented
with 10% FCS (GBICO BRL, Rockville, MD), penicillin
(100 U/mL), and streptomycin (100μg/mL) at 37◦Ci na
humidiﬁed atmosphere of 95% air and 5% CO2. Cells after
the 4th to 8th passages were used in experiments.
2.3. Adenovirus Infection. Recombinant adenoviruses ex-
pressing PGC-1α-GFP (Green Fluorescence Protein) fusion
p r o t e i na n dG F Pa l o n ew e r ep r o v i d e db yD r .D a nK e l l y
(Washington University, Saint Louis, MO, USA). Puriﬁed
virus stocks were prepared through CsCl density gradient
centrifugation [14]. Cells were grown to subconﬂuence,
deprived of serum for 24 hours, and followed by infection
with adenovirus at multiplicities of infection (moi) of 50
for 48 hours. The infection eﬃciency was determined by
ﬂuorescence intensity of GFP.
2.4. RNA Analysis. Total RNA of VSMCs was isolated using
RNeasy kit and RNase-free DNase I. RNA was reverse tran-
scribed into cDNA with oligo (dT) 18 primers and AMV
reverse transcriptase at 42◦C for 1 hour in standard buﬀer
(Table 1).
Quantitative PCR was performed with the ABI Prism
7000 sequence detection system (ABI, Foster City, CA).
SYBR green PCR master mix was used. The reactions were
ampliﬁedfor30sat95◦Cand1minat60◦Cfor40cycles.The
thermal denaturation protocol was run at the end of the PCR
to determine the number of products that were present in
the reaction. All reactions were run in triplicate and included
no template and no reverse transcription controls for each
gene. The relative amount of each mRNA to β-actin RNA
was described using the equation 2-ΔCT where ΔCT =
(CTmRNA − CTβ-actin) [15]. Relative gene expression was
multiplied by 104 in order to simplify the presentation of the
data. The primers used in this study were listed in Table 1.
2.5. Western Blotting Analysis. To obtain total proteins,
V S M C sw e r el y s e di nab u ﬀer containing 10mmol/L HEPES
(pH 7.9), 1.5mmol/L MgCl2, 10mmol/L KCl, and 0.5%
NP-40, and cell lysates were centrifuged at 13000g for
5min. Supernatants were collected as cytosolic extracts for
Western blot. Total proteins were applied to SDS-PAGE gel
electrophoresis for proteins detection. The used primary
antibodies included anti-pgc-1α (sc-13067) and anti-CD68
(sc-9139) from Santa Cruz Biotechnologies, anti-β-actin
(#4967) from Cell Signaling, and anti-α-actin (product no.
A2547) from Sigma. After incubation with primary antibod-
ies for 2h and washing, membranes were incubated with
corresponding horseradish-peroxidase (HRP-) conjugated
secondary antibody and detected with the ECL Plus Kit
(Amersham).
2.6. Migration Assays. Migration assays were performed by
the modiﬁed Boyden chamber [16]. VSMCs were seeded
in 6-well plates (1.5 ×105 cells/well) and grew to subcon-
ﬂuence. After 24h serum deprivation, VSMCs were treated
with adenovirus infection for 48h. Boyden chamber cell
migration assay was performed using transwell chambers
with ﬁbronectin- (Sigma)-coated 8μmp o r e s i z ep o l y c a r -
bonate membranes (BD Biosciences). VSMCs treated were
then suspended in low-glucose (5.5mmol/L) DMEM-0.5%
FBS to a concentration of 4 × 105 cells/mL. Low glucose
(5.5mmol/L) or high glucose (25mmol/L) DMEM (0.6mL)
supplemented with 10% FCS were added to the lower
compartment. A 0.1mL cell suspension (ﬁnal concentration,
4 × 104 cells/well; diameter, 6.5μm) was added to the upper
compartment, and cells were then incubated at 37◦C (95%Journal of Biomedicine and Biotechnology 3
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Figure 1: High glucose stimulated the proliferation, migration, and inﬂammatory gene expression of VSMCs. VSMCs cultured in low-
glucose(5.5mmol/L)orhigh-glucose(25mmol/L)complete mediawere deprived ofserumfor24h.Inproliferationand inﬂammatory gene
expression assays, VSMCs were stimulated by complete media for 6h, respectively. In migration assays, VSMCs were suspended, and then
low-glucose or high-glucose complete media were added to the lower compartment respectively. (a) proliferation of VSMCs, (b) migration
of VSMCs, and (c) inﬂammatory gene expression of VSMCs (∗P<0.05).
air, 5% CO2). 6h later, nonmigrated cells were removed
with a cotton swab, and the migrated cells were ﬁxed with
paraformaldehyde for 30min and stained with crystal violet.
2.7. Proliferation and Phagocytosis Assays by Flow Cytometry.
Click-iT EdU Flow Cytometry Assay Kits (invitrogen, cat.
no. A10202) was used to detect VSMCs proliferation. Cells
seeded in 6-well plates (1.5 × 105 cells/well) were cultured
up to subconﬂuence, and the medium was replaced by
fresh serum-free medium. The cells were then treated
with adenovirus infection for 48h. Following this, low-
glucose (5.5mmol/L) or high-glucose (25mmol/L) DMEM
supplemented with 10% FCS and 10μM EdU were added.
After 6h, cells were suspended at 1 × 107 cells/mL in 1%
BSA in PBS. 100μL of cell suspension and 100μL Click-iT
ﬁxative were added to ﬂow tubes, incubated for 15 minutes
at room temperature, and protected from light. Cells were
washed once with 3mL 1% BSA in PBS. 100μL of the
1X saponin-based permeabilization and wash buﬀer was
added, incubated for the 20 minutes at 4◦Ct e m p e r a t u r e ,
and protected from light. Each tube was washed. 0.5mL
Click-iT reaction cocktail were added, mixed well, incubated
for 30 minutes at room temperature, and protected from
light. Cells were washed once. 0.5mL 1X saponin-based
permeabilization and wash reagent was added. For the
detection of EdU, 633/635nm excitation with red emission
ﬁlter (i.e., 660/20nm or similar) was used.
Phagocytoticactivitywasrevealedbymicrospheres.After
24h serum deprivation, VSMCs were infected by Ad-PGC-
1α or Ad-GFP for 48 hours. Then VSMCs were incubated
with 1μm carboxylate-modiﬁed microspheres with red ﬂu-
orescent (2.7 × 106 b e a d sp e rm L )f o r1 0h .C e l l sw i t ht h e
above treatments were suspended with 0.05% trypsin and
0.02% EDTA and then washed three times in PBS. Follow-
ing this, the cells were analyzed using excitation/emission
maximaof580/605 onFACSCalibur (Becton-Dickinson, San
Jose, CA, USA).
2.8. Statistical Analysis. Data are expressed as means ± SEM.
Data were analyzed using a one-way ANOVA followed by
Fisher’s LSD post hoc test. Calculations were performed
using SPSS/Windows version 12.5S statistical package (SPSS,4 Journal of Biomedicine and Biotechnology
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Figure 2: Overexpression of PGC-1α inhibited proliferation, migration, and inﬂammatory gene expression of VSMCs in high glucose.
VSMCs cultured in high-glucose (25mmol/L) complete media were deprived of serum for 24h. The cells were then treated with adenovirus
infection for 48h. (a) Proliferation of VSMCs, (b) migration of VSMCs, (c) inﬂammatory gene expression of VSMCs (∗P<0.05), and (d)
Western blotting analysis for PGC-1α in VSMCs.
Chicago, IL, USA). In all cases, P<0.05 was taken as statisti-
cally signiﬁcant.
3. Results
3.1. High Glucose Stimulated the Proliferation, Migration, and
Inﬂammatory Gene Expression of VSMCs. VSMCs cultured
in low-glucose (5.5mmol/L) or high-glucose (25mmol/L)
complete media were deprived of serum for 24h. In prolifer-
ation and inﬂammatory gene expression assays, VSMCs were
stimulated by complete media for 6h, respectively, (Figures
1(a) and 1(c)). In migration assays, VSMCs were suspended,
and then low-glucose or high-glucose complete media were
added to the lower compartment, respectively, (Figure 1(b)).
Results showed that the VSMCs in high glucose were in a
preactivated state.
3.2. Overexpression of PGC-1α Inhibited Proliferation, Migra-
tion, and Inﬂammatory Gene Expression of VSMCs Induced by
High Glucose. VSMCs cultured in high glucose (25mmol/L)
complete media were deprived of serum for 24h. The
cells were then treated with adenovirus infection for 48h.
In proliferation and inﬂammatory gene expression assays,
VSMCs were incubated by complete media for 6h (Figures
2(a) and 2(c)). In migration assays, VSMCs were suspended
and then high-glucose complete media was added to the
lower compartment (Figure 2(b)). Results showed that pro-
liferation, migration, and inﬂammatory gene expression of
VSMCs were inhibited. Expression of PGC-1α in VSMCs
treated with adenovirus infection was showed in Figure 2(d).
3.3. Overexpression of PGC-1α Downregulated the VSMCs-
Speciﬁc Genes Expression and Upregulated the Macrophage-
Speciﬁc Genes Expression. To characterize the phenotypic
changes after overexpression of PGC-1α, we determined
the abundance of mRNA for several VSMCs [17]a n d
macrophage-speciﬁc genes at the end of the adenovirus
treatment for 48h. As shown in Figure 3(a), VSMCs infected
by Ad-PGC-1α had dramatically decreased in mRNA levels
of α-actin (57.7% of control, P<0.05), SM22α (59.5%,
P<0.05), smooth muscle myosin heavy chain (31.5%, P<
0.05), and calponin H1 (57.8%, P<0.05). At the same time,Journal of Biomedicine and Biotechnology 5
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Figure 3:OverexpressionofPGC-1αdownregulatedVSMCs-speciﬁcgenesandupregulatedmacrophage-speciﬁcgenes.(a)Downregulation
of VSMCs-speciﬁc genes (∗P<0.05), (b) upregulation of macrophage-speciﬁc genes (∗P<0.05), (c) Western blotting analysis for α-actin
in VSMCs, and (d) Western blotting analysis for CD68 in VSMCs.
the mRNA levels of the macrophage-related proteins (CD68)
increased (569% of control, P<0.05). Another macrophage
marker, Mac-2, increased to 373% of controls (P<0.05)
(Figure 3(b)). ABCA-1, a key regulator of cholesterol eﬄux
from peripheral cells to high-density lipoprotein [18]a n d
associated predominantly with macrophages in vivo [19],
increased to 221% (P<0.05) in VSMCs infected by Ad-
PGC-1α (Figure 3(b)).
Western blot also revealed the presence of speciﬁc
proteins commonly taken as characteristic for VSMC or
macrophage phenotype. Results are showed in Figures 3(c)
and 3(d).
3.4. Phagocytosis of VSMCs. To investigate whether VSMCs
infected by Ad-PGC-1α acquired functional aspects of
macrophages, VSMCs were incubated in 1μm microspheres
with red ﬂuorescent and then assessed by ﬂow cytometry.
As shown in Figure 4, 27.36% of VSMCs infected
by Ad-GFP had phagocytotic activity. However, the pro-
portion of VSMCs having phagocytotic activity increased
to 77.45% after overexpression of PGC-1α. This ﬁnding
indicated that the acquisition of functional properties of
macrophages existed in VSMCs, in addition to the increases
of macrophage-speciﬁc gene and protein expression in
VSMCs.
4. Discussion
Recent studies showed that VSMCs cultured under high-
glucose conditions mimic the diabetic pathophysiological
state, which stimulates VSMCs proliferation, migration, and
inﬂammatory genes expression [6, 20]. High glucose stimu-
lates reactive oxygen species production in cultured vascular
smoothmusclecells[21].ROSshavebeenimplicatedinallof
theseaboveresponsesincludingproliferation[22],migration
[23], and inﬂammatory gene expression of VSMCs [24,
25]. PGC-1α is a major transcriptional regulator of the
mitochondrial detoxiﬁcation system [26–29].
In the current study, we found that high-glucose stim-
ulated VSMCs proliferation, migration, and expression of
MCP-1andIL-6.OverexpressionofPGC-1αbyadenoviruses
infection blocked glucose-induced VSMCs proliferation,
migration,andexpressionofMCP-1andIL-6.Theseimplied
that overexpression of PGC-1α could inhibit the preathero-
genic responses in VSMCs, which were key features in the
pathology of atherosclerosis.
VSMCs maintain considerable plasticity throughout life
and can exhibit a diverse range of diﬀerent phenotypes
in response to changes in local environmental cues [17].
In vascular neointimal lesions, VSMCs display diminished
expression of a number of proteins that are characteristics6 Journal of Biomedicine and Biotechnology
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Figure 4: Phagocytosis of VSMCs. VSMCs deprived of serum for 24h were infected by Ad-PGC-1α or Ad-GFP. After 48h, VSMCs were
incubated with 1μm microspheres (2.7 × 106 beads per mL) for 10h. 27.36% of VSMCs infected by Ad-GFP had phagocytotic activity.
However, the proportion of VSMCs having phagocytotic activity increased to 77.45% after overexpression of PGC-1α.
of fully diﬀerentiated VSMCs [30]. It is well established that
the dediﬀerentiated VSMCs exhibit a number of properties,
including enhanced migration, proliferation, and inﬂamma-
tory gene expression [31].
Given the fact that overexpression of PGC-1α suppressed
the main preatherogenic responses in VSMCs, we examined
the expression of VSMCs-related genes. All four smooth
muscle markers assessed in the present study are related to
the contraction function of VSMCs. Myosin heavy chain
and α-actin are essential components of smooth muscle
contractile machinery [17]. Surprisingly, our results showed
that overexpression of PGC-1α rapidly decreased the genes
expression of commonly accepted markers of the phenotype
of VSMCs. The results were interpreted as evidences for a de-
diﬀerentiation process of VSMCs.
In further experiments, we found that the expres-
sion of macrophage-related genes was induced in VSMCs
by overexpression of PGC-1α, and VSMCs acquired the
macrophage-like functions assessed by phagocytotic activity.
In light of the present results for macrophage-related genes
expression of VSMCs, rather than dediﬀerentiating process,
overexpression of PGC-1α in VSMCs may be more appro-
priately considered as part of a transdiﬀerentiation program
that made VSMCs assume macrophage-like states. VSMCs-
derived foam cells are usually assumed to occur relatively
late in the development of organized atherosclerotic plaque
lesion. They retain suﬃcient phenotypic features to be iden-
tiﬁable by electron microscopy [3]. It has been reported that
downregulation of VSMCs-related genes and Up-regulation
of macrophage-related genes occurred in VSMCs-derived
foam cells [4].
The transdiﬀerentiation was good or bad? Firstly, over-
expression of PGC-1α inhibits the expression of MCP-
1a n dm a k e si td i ﬃcult to attract monocytes to bind to
VSMCs. Then foam cells derived from macrophages would
decrease. Secondly, VSMCs that were transdiﬀerentiated
to macrophage-like state compensated for the decrease
of macrophage. Thirdly, VSMCs have the relative resis-
tance to cholesterol loading-induced toxicity compared with
macrophages, consistent with VSMCs being a more promi-
nent histological feature of the advanced atherosclerotic
lesions [32], which reduced the death of VSMCs and then
favoured plaque stability.
The mechanisms that overexpression of PGC-1α leads
to the conversion of VSMCs to macrophage-like cells
remain unknown. Recent studies demonstrated that two
transcription factors: Liver X receptor α (LXRα)a n dP P A R γ
are strongly regulated by PGC-1α.L X R α is involved in
the transcriptional control of a number of genes regulating
the transport and catabolism of cholesterol [33]. Identiﬁed
target genes of LXRα include the ATP-binding cassette
transporter A1 (ABCA-1) [34], which is involved in reverse
cholesterol transport. In our study, the expression of ABCA-
1 is increased by overexpression of PGC-1α in VSMCs.
Previous studies have indicated that PPARγ regulates gain
of macrophage-like phenotype in primary smooth muscle
culture [35] and showed that the uptake of oxidized LDL
by macrophages or of cholesterol in endothelial cells couldJournal of Biomedicine and Biotechnology 7
lead to PPARγ activation [36, 37]. Future experiments will
be needed to identify the pathways that are responsible for
the transdiﬀerentiation to macrophage-like state in VSMCs.
In summary, we demonstrated that PGC-1α inhibited
glucose-induced proliferation, migration, and inﬂammatory
gene expression in VSMCs. In addition, overexpression of
PGC-1α decreased VSMCs-related genes expression, while
it induced macrophage-related genes expression and phago-
cytosis in VSMCs. PGC-1α transdiﬀerentiated VSMCs to
macrophage-like state. Such transdiﬀerentiation increased
the portion of VSMCs-derived foam cells in the plaque and
then favored plaque stability. PGC-1α may be a potential
target for drug development of atherosclerosis.
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